Financing ·
NeOnc Technologies Holdings redeems all 6,000 Series A Convertible Preferred shares for $5.79 million
NTHINeonc Technologies Holdings, Inc.
NeOnc Technologies Holdings redeemed all 6,000 outstanding shares of its Series A Convertible Preferred Stock for approximately $5.79 million ($965 per share) on September 15, 2026, using proceeds from a recent registered direct offering. The company filed an Elimination of Certificate of Designation with Delaware to terminate the preferred stock designation effective September 18, 2026, eliminating potential dilution and simplifying its capital structure before discounted conversion features became available. NeOnc Technologies Holdings is a clinical-stage biopharmaceutical company developing novel therapies for central nervous system cancers.